You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fremanezumab

Showing 1 - 25 of 36
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Migraine Trial (Fremanezumab, Placebo)

Not yet recruiting
  • Migraine
  • Fremanezumab
  • Placebo
  • (no location specified)
Aug 12, 2022

Migraine Disorders, Sleep Disorder Trial in Boston (Fremanezumab Prefilled Syringe [Ajovy])

Recruiting
  • Migraine Disorders
  • Sleep Disorder
  • Fremanezumab Prefilled Syringe [Ajovy]
  • Boston, Massachusetts
    BIDMC Headaceh Clinic
Mar 16, 2022

Cadasil, Migraine Trial (Fremanezumab, Placebo)

Withdrawn
  • Cadasil
  • Migraine
  • Fremanezumab
  • Placebo
  • (no location specified)
Feb 14, 2022

Chronic Migraine, Headache Trial in Chicago (Combination of Botox + CGRPmAb (Fremanezumab 225mg/1.5mL))

Recruiting
  • Chronic Migraine, Headache
  • Combination of Botox + CGRPmAb (Fremanezumab 225mg/1.5mL)
  • Chicago, Illinois
    Chicago Headache Center & Research Institute
Feb 2, 2023

Interstitial Cystitis Trial (fremanezumab)

Withdrawn
  • Interstitial Cystitis
  • fremanezumab
  • (no location specified)
Nov 5, 2021

AJOVY Subcutaneous Injection for Long-term Use

Recruiting
  • Migraine Disorders
  • Fremanezumab 225 Mg/1.5 mL Subcutaneous Solution
  • Osaka, Japan
    Pharmacovigilance Department
Apr 26, 2022

Fibromyalgia Trial in United States (Fremanezumab - Dose A, Fremanezumab - Dose B, Placebo)

Terminated
  • Fibromyalgia
  • Fremanezumab - Dose A
  • +2 more
  • Birmingham, Alabama
  • +48 more
Jul 1, 2022

Migraine, Migraine With Aura, Migraine Without Aura Trial (Erenumab, Fremanezumab, Galcanezumab)

Recruiting
  • Migraine
  • +4 more
  • Innsbruck, Tirol, Austria
  • +2 more
Oct 19, 2022

Migraine, MDD Trial in Worldwide (Fremanezumab, Placebo)

Completed
  • Migraine
  • Major Depressive Disorder
  • Fremanezumab
  • Placebo
  • Little Rock, Arkansas
  • +63 more
Dec 7, 2022

Migraine Trial in Worldwide (Fremanezumab)

Recruiting
  • Migraine
  • Fremanezumab
  • Phoenix, Arizona
  • +65 more
Aug 23, 2022

Migraine Trial in Worldwide (Fremanezumab)

No longer available
  • Migraine
  • Fremanezumab
  • Brugge, Belgium
  • +22 more
Nov 10, 2021

CGRP Inhibition, Autonomic Function, and Migraine

Recruiting
  • Episodic Migraine
  • Chronic Migraine
  • Vienna, Austria
    Medical University of Vienna
Apr 8, 2022

Chronic Migraine Trial in Zaragoza (A health education programme using a telerehabilitation platform)

Recruiting
  • Chronic Migraine
  • A health education programme using a telerehabilitation platform
  • Zaragoza, Spain
    Hospital Clínico Universitario Lozano Blesa
Mar 21, 2022

Post-Traumatic Headache Trial in United States (Fremanezumab, Placebo)

Completed
Has Results
  • Post-Traumatic Headache
  • Fremanezumab
  • Placebo
  • Phoenix, Arizona
  • +32 more
Nov 5, 2021

Migraine Trial in Ridgeland (Eptinezumab, Erenumab, Onabotulinumtoxin-A)

Recruiting
  • Migraine
  • Gilbert, Arizona
  • +9 more
Nov 9, 2022

Migraine Trial in Worldwide (Fremanezumab, Placebo)

Recruiting
  • Migraine
  • Fremanezumab
  • Placebo
  • Phoenix, Arizona
  • +86 more
Aug 23, 2022

Migraine Trial in Worldwide (Fremanezumab, Placebo)

Recruiting
  • Migraine
  • Fremanezumab
  • Placebo
  • Phoenix, Arizona
  • +86 more
Aug 23, 2022

Migraine Trial in Manhattan Beach (drug, device, other)

Unknown status
  • Migraine
  • Manhattan Beach, California
    Manhattan Beach Orthodontics
Jan 18, 2021

Chronic Migraine Trial in United States (LBR-101 High Dose, LBR-101 Low Dose, Placebo)

Completed
Has Results
  • Chronic Migraine
  • LBR-101 High Dose
  • +2 more
  • Gilbert, Arizona
  • +56 more
Dec 7, 2021

Episodic Migraine Headache Trial in United States (LBR-101 High Dose, LBR-101 Low Dose, Placebo)

Completed
Has Results
  • Episodic Migraine Headache
  • LBR-101 High Dose
  • +2 more
  • Gilbert, Arizona
  • +62 more
Jan 18, 2022

Migraine Prophylaxis Trial in Worldwide (Fremanezumab, Placebo)

Completed
Has Results
  • Migraine Prophylaxis
  • Fremanezumab
  • Placebo
  • Huntsville, Alabama
  • +112 more
Nov 5, 2021

Cluster Headache Trial in Worldwide (Fremanezumab)

Terminated
Has Results
  • Cluster Headache
  • Fremanezumab
  • Phoenix, Arizona
  • +82 more
Nov 6, 2021

Episodic Cluster Headache Trial in Worldwide (Fremanezumab, Placebo)

Terminated
Has Results
  • Episodic Cluster Headache
  • Fremanezumab
  • Placebo
  • Phoenix, Arizona
  • +81 more
Nov 6, 2021

Chronic Cluster Headache Trial in Worldwide (Fremanezumab, Placebo)

Terminated
Has Results
  • Chronic Cluster Headache
  • Fremanezumab
  • Placebo
  • Phoenix, Arizona
  • +82 more
Nov 5, 2021

Migraine Trial in Worldwide (Fremanezumab, Placebo)

Completed
Has Results
  • Migraine
  • Fremanezumab
  • Placebo
  • Birmingham, Alabama
  • +138 more
Nov 6, 2021